<--- Back to Details
First PageDocument Content
Lymphocytic leukemia / Acute leukemia / Leukemia / Acute lymphoblastic leukemia / Hematological malignancy / Anti-CD22 immunotoxin / Rituximab / War on Cancer / Medicine / Oncology / Orphan drugs
Date: 2011-07-20 13:46:55
Lymphocytic leukemia
Acute leukemia
Leukemia
Acute lymphoblastic leukemia
Hematological malignancy
Anti-CD22 immunotoxin
Rituximab
War on Cancer
Medicine
Oncology
Orphan drugs

Add to Reading List

Source URL: home.ccr.cancer.gov

Download Document from Source Website

File Size: 145,69 KB

Share Document on Facebook

Similar Documents

PROTOCOLOTratamiento con Medicamentos Biológicos, Abatacept o Rituximab en adultos con Artritis Reumatoide refractaria al tratamiento habitual

PROTOCOLOTratamiento con Medicamentos Biológicos, Abatacept o Rituximab en adultos con Artritis Reumatoide refractaria al tratamiento habitual

DocID: 1trGJ - View Document

Oncogene, 3530–3540  & 2004 Nature Publishing Group All rights reserved $25.00 www.nature.com/onc  Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10

Oncogene, 3530–3540 & 2004 Nature Publishing Group All rights reserved $25.00 www.nature.com/onc Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10

DocID: 1tpiT - View Document

NOVEMBER 2015 TABLE OF CONTENTS  INTRODUCTION

NOVEMBER 2015 TABLE OF CONTENTS INTRODUCTION

DocID: 1qUAB - View Document

www.edoriumjournals.com  CASE REPORT PEER REVIEWED | OPEN ACCESS

www.edoriumjournals.com CASE REPORT PEER REVIEWED | OPEN ACCESS

DocID: 1qwuZ - View Document

Zevalin Enlarged PI (Page 2)

Zevalin Enlarged PI (Page 2)

DocID: 1qhPE - View Document